FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310777732> ?p ?o ?g. }

• W4310777732 endingPage "106697" @default.
• W4310777732 startingPage "106697" @default.
• W4310777732 abstract "To the authors' knowledge, there is currently no literature or guidance recommendation regarding whether the dose of dolutegravir (DTG) should be increased when co-administered with darunavir/ritonavir (DRV/r) in patients with acute human immunodeficiency virus infection (AHI). This study assessed the pharmacokinetics (PK) of twice-daily (BID) DTG and once-daily (QD) DRV/r, and compared this with DTG QD without DRV/r in patients with AHI. Forty-six participants initiated antiretroviral therapy within <24 h of enrolment: DTG 50 mg BID, DRV/r 800/100 mg QD, and two nucleoside reverse transcriptase inhibitors (NRTIs) for 4 weeks (Phase I); and DTG 50 mg QD with two NRTIs thereafter (Phase II: reference). Total DTG trough concentration (Ctrough) and area under the concentration-time profile of 0-24 h (AUC0-24h) were predicted using a population PK model. DTG glucuronidation metabolic ratio (MR) and DTG free fraction were determined and compared per treatment phase using geometric mean ratio (GMR) and 90% confidence interval (CI). Participants had a predicted geometric mean steady-state DTG Ctrough of 2.83 [coefficient of variation (CV%) 30.3%] mg/L (Phase I) and 1.28 (CV% 52.4%) mg/L (Phase II), with GMR of 2.20 (90% CI 1.90-2.55). Total exposure during DTG BID increased but did not double [AUC0-24h GMR 1.65 (90% CI 1.50-1.81) h.mg/L]. DTG glucuronidation MR increased by approximately 29% during Phase I. DTG Ctrough was above in-vivo EC90 (0.32 mg/L) during both phases, except in one participant during Phase I. At Week 8, 84% of participants had viral loads ≤40 copies/mL. The drug-drug interaction between DTG (BID) and DRV/r (QD) was due to induced glucuronidation, and is not clinically relevant in patients with AHI." @default.
• W4310777732 created "2022-12-17" @default.
• W4310777732 creator A5001375239 @default.
• W4310777732 creator A5018480886 @default.
• W4310777732 creator A5021568119 @default.
• W4310777732 creator A5027401720 @default.
• W4310777732 creator A5043239147 @default.
• W4310777732 creator A5047002646 @default.
• W4310777732 creator A5047029696 @default.
• W4310777732 creator A5056575262 @default.
• W4310777732 creator A5059563743 @default.
• W4310777732 creator A5068511048 @default.
• W4310777732 date "2023-01-01" @default.
• W4310777732 modified "2023-09-26" @default.
• W4310777732 title "Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA)" @default.
• W4310777732 cites W1653851471 @default.
• W4310777732 cites W1990069515 @default.
• W4310777732 cites W2012914963 @default.
• W4310777732 cites W2074118958 @default.
• W4310777732 cites W2098185748 @default.
• W4310777732 cites W2119239704 @default.
• W4310777732 cites W2133117185 @default.
• W4310777732 cites W2135955998 @default.
• W4310777732 cites W2151945046 @default.
• W4310777732 cites W2294678755 @default.
• W4310777732 cites W2496900837 @default.
• W4310777732 cites W2501680897 @default.
• W4310777732 cites W2507203385 @default.
• W4310777732 cites W2513249370 @default.
• W4310777732 cites W2593285831 @default.
• W4310777732 cites W2738986080 @default.
• W4310777732 cites W2755126513 @default.
• W4310777732 cites W2757413803 @default.
• W4310777732 cites W2891129221 @default.
• W4310777732 cites W2894846477 @default.
• W4310777732 cites W2905273924 @default.
• W4310777732 cites W2916449224 @default.
• W4310777732 cites W3023630990 @default.
• W4310777732 cites W3049687827 @default.
• W4310777732 cites W3173776315 @default.
• W4310777732 cites W3217570903 @default.
• W4310777732 doi "https://doi.org/10.1016/j.ijantimicag.2022.106697" @default.
• W4310777732 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36470510" @default.
• W4310777732 hasPublicationYear "2023" @default.
• W4310777732 type Work @default.
• W4310777732 citedByCount "0" @default.
• W4310777732 crossrefType "journal-article" @default.
• W4310777732 hasAuthorship W4310777732A5001375239 @default.
• W4310777732 hasAuthorship W4310777732A5018480886 @default.
• W4310777732 hasAuthorship W4310777732A5021568119 @default.
• W4310777732 hasAuthorship W4310777732A5027401720 @default.
• W4310777732 hasAuthorship W4310777732A5043239147 @default.
• W4310777732 hasAuthorship W4310777732A5047002646 @default.
• W4310777732 hasAuthorship W4310777732A5047029696 @default.
• W4310777732 hasAuthorship W4310777732A5056575262 @default.
• W4310777732 hasAuthorship W4310777732A5059563743 @default.
• W4310777732 hasAuthorship W4310777732A5068511048 @default.
• W4310777732 hasBestOaLocation W43107777321 @default.
• W4310777732 hasConcept C112705442 @default.
• W4310777732 hasConcept C126322002 @default.
• W4310777732 hasConcept C142462285 @default.
• W4310777732 hasConcept C159047783 @default.
• W4310777732 hasConcept C181199279 @default.
• W4310777732 hasConcept C185592680 @default.
• W4310777732 hasConcept C197934379 @default.
• W4310777732 hasConcept C2779182219 @default.
• W4310777732 hasConcept C2779298103 @default.
• W4310777732 hasConcept C2779502633 @default.
• W4310777732 hasConcept C2779907587 @default.
• W4310777732 hasConcept C2908647359 @default.
• W4310777732 hasConcept C2993143319 @default.
• W4310777732 hasConcept C3013748606 @default.
• W4310777732 hasConcept C44249647 @default.
• W4310777732 hasConcept C55493867 @default.
• W4310777732 hasConcept C71924100 @default.
• W4310777732 hasConcept C87644729 @default.
• W4310777732 hasConcept C90924648 @default.
• W4310777732 hasConcept C98274493 @default.
• W4310777732 hasConcept C99454951 @default.
• W4310777732 hasConceptScore W4310777732C112705442 @default.
• W4310777732 hasConceptScore W4310777732C126322002 @default.
• W4310777732 hasConceptScore W4310777732C142462285 @default.
• W4310777732 hasConceptScore W4310777732C159047783 @default.
• W4310777732 hasConceptScore W4310777732C181199279 @default.
• W4310777732 hasConceptScore W4310777732C185592680 @default.
• W4310777732 hasConceptScore W4310777732C197934379 @default.
• W4310777732 hasConceptScore W4310777732C2779182219 @default.
• W4310777732 hasConceptScore W4310777732C2779298103 @default.
• W4310777732 hasConceptScore W4310777732C2779502633 @default.
• W4310777732 hasConceptScore W4310777732C2779907587 @default.
• W4310777732 hasConceptScore W4310777732C2908647359 @default.
• W4310777732 hasConceptScore W4310777732C2993143319 @default.
• W4310777732 hasConceptScore W4310777732C3013748606 @default.
• W4310777732 hasConceptScore W4310777732C44249647 @default.
• W4310777732 hasConceptScore W4310777732C55493867 @default.
• W4310777732 hasConceptScore W4310777732C71924100 @default.
• W4310777732 hasConceptScore W4310777732C87644729 @default.
• W4310777732 hasConceptScore W4310777732C90924648 @default.

• next